Back to results
US 2019/0100568 A1Published application
Interleukin-4 receptor-binding fusion proteins and uses thereof
AssigneeMedicenna Therapeutics Inc.
InventorFahar Merchant
Life of this patent
Estimating the term…
Abstract
The present invention relates to interleukin-4 receptor-binding fusion proteins. More specifically, the invention provides, in part, fusion proteins that include an interleukin-4 or interleukin-13 protein moiety joined to an anti-apoptotic Bcl-2 family member protein moiety.
Claims26
A fusion protein comprising an interleukin-4 (IL-4) receptor binding protein and an anti-apoptotic Bcl-2 family polypeptide.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A nucleic acid molecule comprising the nucleic acid sequence of any one of SEQ ID NOs:
- 30 or 31.
Dependencies are inferred from the claim text.